​

AnaptysBio Ownership | Who Owns AnaptysBio?


OverviewForecastRevenueFinancialsChart

AnaptysBio Ownership Summary


AnaptysBio is owned by 105.37% institutional investors, 5.66% insiders. Ecor1 capital is the largest institutional shareholder, holding 27.47% of ANAB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.39% of its assets in AnaptysBio shares.

ANAB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnaptysBio105.37%5.66%-11.03%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ecor1 capital7.88M27.47%$531.91M
Blackrock1.77M6.47%$44.35M
Blackrock funding, inc. /de1.89M6.46%$95.07M
Vanguard group1.54M5.31%$74.85M
Boxer capital1.30M4.75%$32.58M
Tang capital management1.33M4.64%$89.83M
State street1.15M3.92%$57.59M
Vanguard capital management909.95K3.11%$45.73M
Millennium management807.32K2.81%$54.49M
Sanofi821.92K2.81%$41.31M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ecor1 capital7.88M25.86%$531.91M
Sanofi821.92K6.56%$41.31M
Greenhaven road investment management145.70K5.65%$7.32M
Palo alto investors lp603.49K5.63%$40.74M
Crcm lp181.11K5.05%$9.10M
Tang capital management1.33M4.08%$89.83M
Apis capital advisors444.00K3.15%$22.32M
First light asset management582.00K2.39%$39.29M
683 capital management660.00K2.19%$44.55M
Sofinnova investments493.54K1.72%$33.31M

Top Buyers

HolderShares% AssetsChange
Pertento partners llp545.00K1.31%545.00K
Woodline partners lp717.01K0.15%372.76K
Millennium management807.32K0.02%331.74K
Goldman sachs group584.07K0.00%251.33K
Sofinnova investments493.54K1.72%245.28K

Top Sellers

HolderShares% AssetsChange
Fairmount funds management---1.82M
Frazier life sciences management---1.57M
Assenagon asset management---839.93K
Affinity asset advisors66.46K0.14%-759.64K
Camber capital management lp125.00K0.26%-625.00K

New Positions

HolderShares% AssetsChangeValue
Pertento partners llp545.00K1.31%545.00K$27.39M
Crcm lp181.11K5.05%181.11K$9.10M
Diamond hill capital management170.11K0.09%170.11K$8.55M
Lmr partners llp140.72K0.02%140.72K$1.86M
Ruffer llp106.75K0.15%106.75K$3.04M

Sold Out

HolderChange
Advisory services network-3.00
Nelson, van denburg & campbell wealth management group-4.00
Twin peaks wealth advisors-5.00
Northwestern mutual wealth management-7.00
National bank of canada /fi/-8.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20262355.86%30,836,3011.60%1050.94%14218.33%61-10.29%
Jun 30, 20262183.81%30,301,3427.32%1050.48%11811.32%67-6.94%
Mar 31, 202682-55.19%4,219,141-85.63%220.22%42-52.81%22-65.08%
Dec 31, 202536-79.55%1,861,311-94.12%60.05%17-77.63%10-83.61%
Sep 30, 202556-63.16%4,268,326-88.39%140.09%20-72.60%23-56.60%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF733.95K2.39%129.10K
State Street® SPDR® S&P® Biotech ETF687.10K2.30%17.96K
Vanguard Morn Total Stk Mkt Idx Investor648.15K2.19%8.10K
Vanguard Total Stock Mkt Idx Inv648.15K2.19%8.10K
Vanguard MStar Total Stk Mkt Idx Invest648.15K2.17%-
Fidelity Small Cap Growth625.15K2.13%-
iShares Russell 2000 ETF508.11K1.70%-
US Small-Cap Growth II Equity Comp440.07K1.50%-105.21K
T. Rowe Price New Horizons371.08K1.33%-68.99K
SPDR® S&P Biotech ETF326.85K1.17%730.00

Recent Insider Transactions


DateNameRoleActivityValue
Oct 01, 2026RENTON HOLLINGS-Sell$249.37K
Mar 30, 2026Schmid John P.-Sell$29.96K
Mar 30, 2026Schmid John P.-Sell$701.71K
Mar 30, 2026Schmid John P.-Sell$426.78K
Mar 27, 2026Faga Daniel President, CEOSell$28.87K

Insider Transactions Trends


DateBuySell
2026 Q4-1
2026 Q3--
2026 Q2--
2026 Q1-31
2025 Q4-10

ANAB Ownership FAQ


Who Owns AnaptysBio?

AnaptysBio shareholders are primarily institutional investors at 105.37%, followed by 5.66% insiders and -11.03% retail investors. The average institutional ownership in AnaptysBio's industry, Biotech Stocks , is 181.71%, which AnaptysBio falls below.

Who owns the most shares of AnaptysBio?

AnaptysBio’s largest shareholders are Ecor1 capital (7.88M shares, 27.47%), Blackrock (1.77M shares, 6.47%), and Blackrock funding, inc. /de (1.89M shares, 6.46%). Together, they hold 40.40% of AnaptysBio’s total shares outstanding.

Does Blackrock own AnaptysBio?

Yes, BlackRock owns 6.47% of AnaptysBio, totaling 1.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 44.35M$. In the last quarter, BlackRock increased its holdings by 49.89K shares, a 2.90% change.

Who is AnaptysBio’s biggest shareholder by percentage of total assets invested?

Ecor1 capital is AnaptysBio’s biggest shareholder by percentage of total assets invested, with 25.86% of its assets in 7.88M AnaptysBio shares, valued at 531.91M$.

Who is the top mutual fund holder of AnaptysBio shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of AnaptysBio shares, with 2.39% of its total shares outstanding invested in 733.95K AnaptysBio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools